Study details
Enrolling now
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
NCT IDNCT07447050ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
18+
Locations
1 site in CA
About this study
This Phase 2 study is testing Riluzole in people with breast cancer.
Based on ClinicalTrials.gov records.
PhasePhase 2
DrugRiluzole
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
riluzole
Drug routes
oral (Oral Tablet)
Body systems
Oncology